Why Do Early-Onset FSHD Patients Need Eye & Hearing Exams?
At a Glance
Early-onset FSHD can affect blood vessels in the retina and sensory nerves in the inner ear, leading to silent vision damage and high-frequency hearing loss. Routine dilated eye exams and audiometry are essential to catch these issues early and protect a child's development.
When a child is diagnosed with early-onset (also called infantile) Facioscapulohumeral muscular dystrophy (FSHD), discovering that they need frequent, specialized eye and hearing exams can feel overwhelming. However, these proactive screenings are a powerful way to protect your child’s development and well-being. The genetic changes that cause early-onset FSHD—specifically, very short D4Z4 repeats (usually 1 to 3 repeats)—affect more than just skeletal muscles [1]. In these early-onset cases, the disease can also impact the blood vessels in the retina and the sensory nerves in the inner ear [2][3]. Frequent screening is essential because these changes often show no obvious symptoms early on, but they are highly manageable when caught quickly [4].
The Link Between FSHD, Eyes, and Ears
FSHD is caused by the abnormal activation of a gene called DUX4, which is normally turned off in most of the body’s cells [5]. In patients with early-onset FSHD, a larger portion of genetic material is missing (fewer D4Z4 repeats), which allows the DUX4 gene to become highly active and cause more severe disease [5][1]. While this primarily causes progressive muscle weakness, the systemic effects of the disease can also damage fragile cells in the eyes and ears [6].
Protecting Vision: Exudative Retinopathy
Children with early-onset FSHD and large genetic deletions have a higher risk of developing leaky blood vessels in the eye, a condition called exudative retinopathy (which closely resembles Coats’ disease) [4][7].
- What happens: Abnormal blood vessels grow in the retina (the light-sensitive tissue at the back of the eye) and begin to leak fluid or blood [4].
- The risk: If left undetected for too long, this fluid buildup can lead to retinal scarring and permanent vision loss [4].
- Why screening matters: Exudative retinopathy is often completely silent in its early stages [4]. A specialized test called a dilated indirect ophthalmoscopy allows a pediatric eye doctor to look deep into the retina and spot these leaking vessels before they cause damage.
- What treatment looks like: If caught early, these abnormal vessels can be successfully treated with minimally invasive procedures like laser therapy or cryotherapy (freezing) to seal the leaks and preserve the child’s vision [4].
- What to expect during the exam: The doctor will use eye drops to widen (dilate) your child’s pupils. While the drops might sting briefly and make their eyes sensitive to light for a few hours, the exam itself is painless. For very young or squirmy children, pediatric eye specialists are trained to make the process as quick and distraction-filled as possible.
Protecting Hearing and Development: Sensorineural Hearing Loss
Hearing changes are another well-documented complication of early-onset FSHD [8].
- What happens: Children can develop sensorineural hearing loss, meaning the issue lies in the inner ear or the nerve pathways [9]. In FSHD, this typically affects the ability to hear high-frequency (high-pitched) sounds first [4].
- The risk: Because a child might still hear lower pitches clearly, high-frequency hearing loss is easy to miss at home. If undetected, missing these sounds can interfere with speech milestones and language development [4].
- Why screening matters: Routine audiometry (hearing tests) can detect these specific high-pitch deficits early [4]. Early detection is incredibly empowering—it allows your care team to promptly introduce interventions like hearing aids or speech therapy, ensuring your child’s language development and learning stay right on track [4].
Recommended Screening Guidelines
To protect your child during their most critical developmental windows, consensus guidelines from organizations like the American Academy of Neurology (AAN) emphasize proactive monitoring for early-onset patients [4]:
- At Diagnosis: A comprehensive baseline audiometry test and a dilated indirect ophthalmoscopy should be performed as soon as the child is diagnosed [4].
- Ongoing Monitoring: Annual follow-up screenings are highly recommended, particularly for children with the shortest D4Z4 repeat lengths (1-3) [4]. Regular monitoring ensures that any changes to their vision or hearing are caught and addressed immediately as they grow [4].
Common questions in this guide
Why does early-onset FSHD affect the eyes and ears?
What is exudative retinopathy in children with FSHD?
What kind of hearing loss is associated with early-onset FSHD?
How often should a child with early-onset FSHD have eye and hearing exams?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What is the exact D4Z4 repeat count confirmed by my child's genetic testing, and how does that specific number inform our screening schedule?
- 2.Which pediatric ophthalmologist and pediatric audiologist in our area have experience with rare neuromuscular diseases like FSHD?
- 3.What specific signs or symptoms should I watch for at home that might indicate early vision or hearing changes?
- 4.If exudative retinopathy is detected, what treatments (like laser therapy) would you recommend to prevent vision loss?
- 5.How often will my child need dilated eye exams and audiometry moving forward, and at what age might that frequency decrease?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (9)
- 1
FSHD1 Diagnosis in a Russian Population Using a qPCR-Based Approach.
Zernov NV, Guskova AA, Skoblov MY
Diagnostics (Basel, Switzerland) 2021; (11(6)) doi:10.3390/diagnostics11060982.
PMID: 34071558 - 2
Early onset facioscapulohumeral dystrophy - a systematic review using individual patient data.
Goselink RJM, Voermans NC, Okkersen K, et al.
Neuromuscular disorders : NMD 2017; (27(12)):1077-1083 doi:10.1016/j.nmd.2017.09.007.
PMID: 29102079 - 3
Early onset as a marker for disease severity in facioscapulohumeral muscular dystrophy.
Goselink RJM, Mul K, van Kernebeek CR, et al.
Neurology 2019; (92(4)):e378-e385 doi:10.1212/WNL.0000000000006819.
PMID: 30568007 - 4
Evidence-based guideline summary: Evaluation, diagnosis, and management of facioscapulohumeral muscular dystrophy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the Practice Issues Review Panel of the American Association of Neuromuscular & Electrodiagnostic Medicine.
Tawil R, Kissel JT, Heatwole C, et al.
Neurology 2015; (85(4)):357-64 doi:10.1212/WNL.0000000000001783.
PMID: 26215877 - 5
Inflammatory facioscapulohumeral muscular dystrophy type 2 in 18p deletion syndrome.
Renard D, Taieb G, Garibaldi M, et al.
American journal of medical genetics. Part A 2018; (176(8)):1760-1763 doi:10.1002/ajmg.a.38843.
PMID: 30055030 - 6
Systemic manifestations and symptom burden of facioscapulohumeral muscular dystrophy in a referral cohort.
Kelly CR, Saw JL, Thapa P, et al.
Muscle & nerve 2022; (65(4)):415-421 doi:10.1002/mus.27493.
PMID: 35020192 - 7
Coats-like Retinopathy Associated With 18p Deletion Syndrome.
Williams JE, Recchia FM
Ophthalmic surgery, lasers & imaging retina 2025; (56(10)):629-632 doi:10.3928/23258160-20250718-02.
PMID: 40788857 - 8
Hearing Loss, Retinal Abnormality, and Seizures in People With Facioscapulohumeral Muscular Dystrophy.
Kilburn SN, Thomas S, Havlik AL, et al.
Muscle & nerve 2025; (72(5)):1156-1160 doi:10.1002/mus.70007.
PMID: 40879179 - 9
GGPS1 Mutations Cause Muscular Dystrophy/Hearing Loss/Ovarian Insufficiency Syndrome.
Foley AR, Zou Y, Dunford JE, et al.
Annals of neurology 2020; (88(2)):332-347 doi:10.1002/ana.25772.
PMID: 32403198
This page provides educational information about screening guidelines for early-onset FSHD. Always consult your pediatric neurologist, ophthalmologist, and audiologist for personalized medical advice and screening schedules.
Get notified when new evidence is published on Facioscapulohumeral dystrophy.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.